Phase 1/2 Open-label Dose-escalation Study of Plasmid DNA Expressing Two Isoforms of Hepatocyte Growth Factor in Patients With Painful Diabetic Peripheral Neuropathy-Reference-Cited by-同舟云学术

Phase 1/2 Open-label Dose-escalation Study of Plasmid DNA Expressing Two Isoforms of Hepatocyte Growth Factor in Patients With Painful Diabetic Peripheral Neuropathy

Published:2013-06 Issue:6 Volume:21 Page:1279-1286
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ajroud-Driss Senda,Christiansen Mark,Allen Jeffrey A,Kessler John A

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference41 articles.

1. Diabetic neuropathy: clinical manifestations and current treatments;Callaghan;Lancet Neurol,2012

2. Diabetic neuropathy: mechanisms to management;Edwards;Pharmacol Ther,2008

3. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy;Tesfaye;Diabetes Metab Res Rev,2012

4. Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management;Tesfaye;Diabetes Metab Res Rev,2011

5. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes;Davies;Diabetes Care,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant Human Hepatocyte Growth Factor Plasmids for Treating Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-analysis;European Journal of Vascular and Endovascular Surgery;2024-07

2. Stem cell therapy combined with controlled release of growth factors for the treatment of sphincter dysfunction;Cell & Bioscience;2023-03-16

3. Novel rAAV vector mediated intrathecal HGF delivery has an impact on neuroimmune modulation in the ALS motor cortex with TDP-43 pathology;Gene Therapy;2023-02-24

4. Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled, double-blind, phase III clinical trials;American Heart Journal;2022-12

5. Gabapentin inhibits the analgesic effects and nerve regeneration process induced by hepatocyte growth factor (HGF) in a peripheral nerve injury model: Implication for the use of VM202 and gabapentinoids for peripheral neuropathy;Molecular and Cellular Neuroscience;2022-09